These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability. Salaffi F, Carotti M, Di Donato E, Di Carlo M, Ceccarelli L, Giuseppetti G. PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658 [Abstract] [Full Text] [Related]
6. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR. Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780 [Abstract] [Full Text] [Related]
7. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J. Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033 [Abstract] [Full Text] [Related]
8. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463 [Abstract] [Full Text] [Related]
10. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Deuschle K, Weinert K, Becker MO, Backhaus M, Huscher D, Riemekasten G. Clin Exp Rheumatol; 2011 Feb; 29(2 Suppl 65):S53-9. PubMed ID: 21586219 [Abstract] [Full Text] [Related]
11. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis. Lumetti F, Barone L, Alfieri C, Silva M, Serra V, Delsante G, Sverzellati N, Ariani A. Acta Biomed; 2015 Sep 14; 86(2):142-8. PubMed ID: 26422428 [Abstract] [Full Text] [Related]
12. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience. Demir N, Şahin A, Küçükşahin O, Kayacan O, Dinçer İ, Sayın T, Karnak D, Turgay M. Heart Lung Circ; 2014 Jul 14; 23(7):667-73. PubMed ID: 24613044 [Abstract] [Full Text] [Related]
13. The relationship between changes in self-reported disability (measured by the Health Assessment Questionnaire - HAQ) in scleroderma and improvement of disease status in clinical practice. Lawrence E, Pope J, Al Zahraly Z, Lalani S, Baron M. Clin Exp Rheumatol; 2009 Jul 14; 27(3 Suppl 54):32-7. PubMed ID: 19796559 [Abstract] [Full Text] [Related]
14. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis. Hesselstrand R, Nilsson JÅ, Sandqvist G. Scand J Rheumatol; 2013 Jul 14; 42(4):317-24. PubMed ID: 23442162 [Abstract] [Full Text] [Related]
15. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement. Abdel-Magied RA, Kamel SR, Said AF, Ali HM, Abdel Gawad EA, Moussa MM. Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec 23; 33(4):321-330. PubMed ID: 28079844 [Abstract] [Full Text] [Related]
16. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group. Arthritis Rheum; 2005 Feb 23; 52(2):592-600. PubMed ID: 15692967 [Abstract] [Full Text] [Related]
18. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients. Vandecasteele E, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Thevissen K, Brusselle G, Smith V. Clin Exp Rheumatol; 2018 Feb 23; 36 Suppl 113(4):95-101. PubMed ID: 30183593 [Abstract] [Full Text] [Related]
20. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Steen VD, Medsger TA. Arthritis Rheum; 1997 Nov 23; 40(11):1984-91. PubMed ID: 9365087 [Abstract] [Full Text] [Related] Page: [Next] [New Search]